Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695).

Thomas W Flaig,Catherine M Tangen,Siamak Daneshmand,Ajjai Shivaram Alva,M Scott Lucia,David James McConkey,Dan Theodorescu,Amir Goldkorn,Matthew I Milowsky,Rick Bangs,Gary R MacVicar,Bruno R Bastos,Jared S Fowles,Daniel L Gustafson,Melissa Plets,Ian M Thompson,Seth P Lerner

European urology（2023）

引用 0|浏览22

暂无评分

摘要

In this study, we evaluated a biomarker to predict the response to chemotherapy. The results did not meet the preset study parameters, but our study provides information on clinical outcomes with the use of chemotherapy before surgery for bladder cancer.

查看译文

关键词

Biomarkers,Cystectomy,Neoadjuvant chemotherapy,Urinary bladder cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要